// Add required javascript and css files to the header var headelement = document.getElementsByTagName('head')[0]; var wjs = document.createElement('script'); wjs.setAttribute('type', 'text/javascript'); wjs.setAttribute('src', 'http://cdn.ftdata.co.uk/widgetsupport/alljavascript?v=4'); headelement.appendChild(wjs); var wcss = document.createElement('link'); wcss.setAttribute('rel', 'stylesheet'); wcss.setAttribute('type', 'text/css'); wcss.setAttribute('href', 'http://cdn.ftdata.co.uk/widgetsupport/irwidgets.css?v=4'); headelement.appendChild(wcss); var irwidgetssipageid = 'Companies research for APH:LSE'; if (!document.body.getAttribute("si:pageID") && typeof(SiSetPageID) == "function") { SiSetPageID(irwidgetssipageid); } // Output the widgets document.write('

Investor Relations Information from Alliance Pharma

Annual Reports

Further Information

Investor Contact

Please contact John Dawson or Richard Wright at:
ir@alliancepharma.co.uk

Board of Directors

1/5 - Chairman, Michael R B Gatenby2/5 - Chief Executive Officer, John Dawson3/5 - Director Cambridge Laboratories, Peter Butterfield4/5 - Director Alliance Pharmaceuticals, Tony Booley5/5 - Finance Director & Company Secretary, Richard Wright

1/5 - Chairman, Michael R B Gatenby

');